Your session is about to expire
← Back to Search
e-assist: Colon Health for Colorectal Cancer
N/A
Waitlist Available
Led By Jennifer Elston Lafata, PhD
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
-CRC screening recommendation via colonoscopy and/or stool cards at time of primary care appointment. Receiving care in a HFHS primary care clinic and activated MyChart account.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial is comparing patient perceptions, intent to screen, and screening use among those using a patient portal with and without a colorectal cancer (CRC) screening decision support tool, e-assist.
Eligible Conditions
- Colorectal Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
CRC Screening use
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: e-assist: Colon Health (treatment arm)Experimental Treatment1 Intervention
Eligible patients identified will receive a prompt (via email) to log into portal for an important health message. Once eligible patient initiates portal session, continuing past IRB consent screen, patient is enrolled.
Group II: Healthwise Educational Program (active control)Active Control1 Intervention
Eligible patients identified will receive a prompt (via email) to log into portal for an important health message. Once eligible patient initiates portal session, continuing past IRB consent screen, patient is enrolled.
Group III: Usual care control (observational only)Active Control1 Intervention
There will be no participant contact in this arm. We will use existing data sources only (e.g., EHRs) to obtain information on participants in this arm (i.e., an observational data review only).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
e-assist: Colon Health
2017
N/A
~1830
Find a Location
Who is running the clinical trial?
UNC Lineberger Comprehensive Cancer CenterLead Sponsor
350 Previous Clinical Trials
86,426 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,651 Previous Clinical Trials
40,931,104 Total Patients Enrolled
Jennifer Elston Lafata, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger